Last 12 months
Inside the activity.
0 purchase rows · 65 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 21 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 94 | $313.00 | $29,422.00 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 13 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,652 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 200 | $311.94 | $62,388.00 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 12 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,746 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F12 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $311.85 to $312.03, inclusive. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 200 | $310.78 | $62,156.00 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 11 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,946 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F11 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $310.77 to $310.79, inclusive. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 200 | $310.01 | $62,002.00 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 10 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,146 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F10 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $309.69 to $310.33, inclusive. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,000 | $308.84 | $308,838.00 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 9 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,346 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F9 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $308.38 to $309.35, inclusive. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 900 | $307.79 | $277,013.97 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 8 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,346 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F8 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $307.32 to $308.30, inclusive. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 700 | $306.62 | $214,634.98 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 7 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,246 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $306.28 to $307.05, inclusive. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 700 | $305.79 | $214,053.98 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 6 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,946 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $305.26 to $306.25, inclusive. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 600 | $304.22 | $182,530.02 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,646 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $304.06 to $304.50, inclusive. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 900 | $303.45 | $273,101.04 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,246 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $303.01 to $303.84, inclusive. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 506 | $302.55 | $153,087.77 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,146 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $301.97 to $302.96, inclusive. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 600 | $301.10 | $180,658.98 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,652 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.78 to $301.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 22:07 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000240 · wf-form4_163917401046006.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · derivative · entry 17 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $303.08 | $30,308.00 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 15 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $292.03 | $29,203.00 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 14 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,863 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 7 | $286.85 | $2,007.95 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 13 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,963 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 185 | $285.10 | $52,742.74 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 12 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,970 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $284.95 to $285.22, inclusive. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 200 | $282.79 | $56,557.00 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 11 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,155 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $282.55 to $283.02, inclusive. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $280.68 | $28,068.00 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 10 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,355 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $278.13 | $27,813.00 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 9 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,455 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 301 | $274.62 | $82,660.35 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 8 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,555 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $274.35 to $275.13, inclusive. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $273.16 | $27,316.00 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 7 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,856 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 97 | $271.98 | $26,381.68 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 6 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,956 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $271.97 to $272.56, inclusive. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 310 | $271.39 | $84,130.96 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,053 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $270.93 to $271.91, inclusive. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 200 | $270.17 | $54,034.00 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,363 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.71 to $270.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $267.96 | $26,796.00 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 3 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,563 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $266.14 | $26,614.00 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 2 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,663 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021 Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 22:20 UTC |
BLASING KARENDirector
|
Exercise / conversionCommon Stock | 2,000 | $5.82 | $11,640.00 |
DisclosureSEC source: 0001713683-21-000232 · wf-form4_163891563255081.xml · nonDerivative · entry 1 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:04 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.93 | $0.00 |
DisclosureSEC source: 0001713683-21-000225 · wf-form4_163779505391965.xml · derivative · entry 18 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,333 Underlying: Common Stock · 7,000 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F18 · derivative.exercise_date: One-fourth of the shares subject to the option vest on November 1, 2018 and 1/48 of the shares vest monthly thereafter. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:04 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,568 | $342.40 | $536,881.16 |
DisclosureSEC source: 0001713683-21-000225 · wf-form4_163779505391965.xml · nonDerivative · entry 11 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,252 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F11 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $342.10 to $342.84, inclusive. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:04 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 2,103 | $341.59 | $718,365.03 |
DisclosureSEC source: 0001713683-21-000225 · wf-form4_163779505391965.xml · nonDerivative · entry 10 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,820 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F10 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $341.01 to $342.00, inclusive. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:04 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 1,100 | $340.54 | $374,590.04 |
DisclosureSEC source: 0001713683-21-000225 · wf-form4_163779505391965.xml · nonDerivative · entry 9 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,923 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F9 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $339.99 to $340.93, inclusive. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:04 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 600 | $339.28 | $203,569.02 |
DisclosureSEC source: 0001713683-21-000225 · wf-form4_163779505391965.xml · nonDerivative · entry 8 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,023 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F8 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $338.85 to $339.70, inclusive. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:04 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 300 | $338.42 | $101,525.01 |
DisclosureSEC source: 0001713683-21-000225 · wf-form4_163779505391965.xml · nonDerivative · entry 7 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,623 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $337.85 to $338.83, inclusive. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:04 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 300 | $336.66 | $100,998.99 |
DisclosureSEC source: 0001713683-21-000225 · wf-form4_163779505391965.xml · nonDerivative · entry 6 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,923 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $336.58 to $336.78, inclusive. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:04 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 229 | $334.76 | $76,659.33 |
DisclosureSEC source: 0001713683-21-000225 · wf-form4_163779505391965.xml · nonDerivative · entry 5 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,223 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $334.74 to $334.77, inclusive. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:04 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 200 | $333.41 | $66,682.00 |
DisclosureSEC source: 0001713683-21-000225 · wf-form4_163779505391965.xml · nonDerivative · entry 4 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,452 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $332.99 to $333.83, inclusive. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:04 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 300 | $331.76 | $99,527.01 |
DisclosureSEC source: 0001713683-21-000225 · wf-form4_163779505391965.xml · nonDerivative · entry 3 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,652 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F3 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $331.29 to $331.99, inclusive. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:04 UTC |
Sinha AmitDirector · President of R&D and CTO
|
SaleCommon Stock | 300 | $329.95 | $98,985.99 |
DisclosureSEC source: 0001713683-21-000225 · wf-form4_163779505391965.xml · nonDerivative · entry 2 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,952 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.91 to $330.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 23:04 UTC |
Sinha AmitDirector · President of R&D and CTO
|
Exercise / conversionCommon Stock | 7,000 | $5.93 | $41,475.00 |
DisclosureSEC source: 0001713683-21-000225 · wf-form4_163779505391965.xml · nonDerivative · entry 1 Sinha Amit · CIK 0001733850 · Director · President of R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:07 UTC |
BLASING KARENDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001713683-21-000220 · wf-form4_163770162598323.xml · derivative · entry 12 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,334 Underlying: Common Stock · 2,000 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:07 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $366.68 | $36,668.00 |
DisclosureSEC source: 0001713683-21-000220 · wf-form4_163770162598323.xml · nonDerivative · entry 11 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · shares: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:07 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $364.94 | $36,494.00 |
DisclosureSEC source: 0001713683-21-000220 · wf-form4_163770162598323.xml · nonDerivative · entry 10 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,863 F1 · shares: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:07 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 98 | $264.44 | $25,915.54 |
DisclosureSEC source: 0001713683-21-000220 · wf-form4_163770162598323.xml · nonDerivative · entry 9 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,963 F1 · shares: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F7 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $363.69 to $364.65, inclusive. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:07 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 243 | $359.97 | $87,473.22 |
DisclosureSEC source: 0001713683-21-000220 · wf-form4_163770162598323.xml · nonDerivative · entry 8 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,061 F1 · shares: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F6 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $359.75 to $360.54, inclusive. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:07 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $357.45 | $35,745.00 |
DisclosureSEC source: 0001713683-21-000220 · wf-form4_163770162598323.xml · nonDerivative · entry 7 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,304 F1 · shares: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:07 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 100 | $352.71 | $35,271.00 |
DisclosureSEC source: 0001713683-21-000220 · wf-form4_163770162598323.xml · nonDerivative · entry 6 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,404 F1 · shares: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:07 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 200 | $348.61 | $69,722.00 |
DisclosureSEC source: 0001713683-21-000220 · wf-form4_163770162598323.xml · nonDerivative · entry 5 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,504 F1 · shares: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F5 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $348.37 to $348.85, inclusive. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:07 UTC |
BLASING KARENDirector
|
SaleCommon Stock | 200 | $346.84 | $69,368.00 |
DisclosureSEC source: 0001713683-21-000220 · wf-form4_163770162598323.xml · nonDerivative · entry 4 BLASING KAREN · CIK 0001256358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,704 F1 · shares: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on January 2, 2021. F4 · price: The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $346.70 to $346.98, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.